Exelixis Inc Income Tax Expense
Exelixis Inc (EXEL) reported Income Tax Expense of $50.63 million for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-05
- Exelixis Inc income tax expense (benefit) for the quarter ending 2026-07-03 was $50.63M, a 11.11% increase year-over-year.
- Exelixis Inc income tax expense (benefit) for the quarter ending 2026-04-03 was $57.22M, a 24.19% increase year-over-year.
- Exelixis Inc income tax expense (benefit) for the quarter ending 2026-01-02 was $8.16M, a 81.83% decline year-over-year.
- Exelixis Inc income tax expense (benefit) for the quarter ending 2025-10-03 was $58.84M, a 59.96% increase year-over-year.
- Exelixis Inc income tax expense (benefit) for fiscal 2026 was $158.64M, a 1.08% decline from fiscal 2025.
- Exelixis Inc income tax expense (benefit) for fiscal 2025 was $160.37M, a 222.32% increase from fiscal 2023.
- Exelixis Inc income tax expense (benefit) for fiscal 2023 was $49.76M, a 4.44% decline from fiscal 2022.
- Exelixis Inc income tax expense (benefit) for fiscal 2022 was $52.07M, a 17.47% decline from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-07-03 | $50.63M 10-Q · filed 2026-08-05 | $107.85M 10-Q · filed 2026-08-05 | $116.01M derived: sum of 3 quarters · filed 2026-08-05 | $174.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-04-03 | $57.22M 10-Q · filed 2026-05-05 | $65.38M derived: sum of 2 quarters · filed 2026-05-05 | $124.22M derived: sum of 3 quarters · filed 2026-05-05 | $169.78M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-01-02 | $8.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $67.00M derived: sum of 2 quarters · filed 2026-02-10 | $112.56M derived: sum of 3 quarters · filed 2026-08-05 | $158.64M 10-K · filed 2026-02-10 |
| 2025-10-03 | $58.84M 10-Q · filed 2025-11-04 | $104.40M derived: sum of 2 quarters · filed 2026-08-05 | $150.48M 10-Q · filed 2025-11-04 | $195.39M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-07-04 | $45.57M 10-Q · filed 2026-08-05 | $91.64M 10-Q · filed 2026-08-05 | $136.55M derived: sum of 3 quarters · filed 2026-08-05 | $173.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-04-04 | $46.07M 10-Q · filed 2026-05-05 | $90.99M derived: sum of 2 quarters · filed 2026-05-05 | $127.77M derived: sum of 3 quarters · filed 2026-05-05 | $194.50M derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-01-03 | $44.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $81.69M derived: sum of 2 quarters · filed 2026-02-10 | $148.42M derived: sum of 3 quarters · filed 2026-02-10 | $160.37M 10-K · filed 2026-02-10 |
| 2024-09-27 | $36.78M 10-Q · filed 2025-11-04 | $103.51M derived: sum of 2 quarters · filed 2025-11-04 | $115.46M 10-Q · filed 2025-11-04 | $132.98M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-28 | $66.73M 10-Q · filed 2025-07-28 | $78.68M 10-Q · filed 2025-07-28 | $96.20M derived: sum of 3 quarters · filed 2026-02-10 | $100.98M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-29 | $11.95M 10-Q · filed 2025-05-13 | $29.47M derived: sum of 2 quarters · filed 2026-02-10 | $34.25M derived: sum of 3 quarters · filed 2026-02-10 | $53.46M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-29 | $17.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $22.30M derived: sum of 2 quarters · filed 2026-02-10 | $41.51M derived: sum of 3 quarters · filed 2026-02-10 | $49.76M 10-K · filed 2026-02-10 |
| 2023-09-29 | $4.78M 10-Q · filed 2024-10-29 | $23.98M derived: sum of 2 quarters · filed 2024-10-29 | $32.23M 10-Q · filed 2024-10-29 | $30.98M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $19.21M 10-Q · filed 2024-08-06 | $27.46M 10-Q · filed 2024-08-06 | $26.20M derived: sum of 3 quarters · filed 2025-02-11 | $45.04M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $8.25M 10-Q · filed 2024-04-30 | $7.00M derived: sum of 2 quarters · filed 2025-02-11 | $25.83M derived: sum of 3 quarters · filed 2025-02-11 | $43.66M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-30 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $17.58M derived: sum of 2 quarters · filed 2025-02-11 | $35.41M derived: sum of 3 quarters · filed 2025-02-11 | $52.07M 10-K · filed 2025-02-11 |
| 2022-09-30 | $18.83M 10-Q · filed 2023-11-01 | $36.67M derived: sum of 2 quarters · filed 2023-11-01 | $53.32M 10-Q · filed 2023-11-01 | $76.18M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-07-01 | $17.84M 10-Q · filed 2023-08-01 | $34.49M 10-Q · filed 2023-08-01 | $57.35M derived: sum of 3 quarters · filed 2024-02-06 | $72.40M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-04-01 | $16.66M 10-Q · filed 2023-05-09 | $39.51M derived: sum of 2 quarters · filed 2024-02-06 | $54.57M derived: sum of 3 quarters · filed 2024-02-06 | $83.36M derived: sum of 4 quarters · filed 2024-02-06 |
| 2021-12-31 | $22.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-06 | $37.91M derived: sum of 2 quarters · filed 2024-02-06 | $66.71M derived: sum of 3 quarters · filed 2024-02-06 | $63.09M 10-K · filed 2024-02-06 |
| 2021-10-01 | $15.06M 10-Q · filed 2022-11-01 | $43.85M derived: sum of 2 quarters · filed 2022-11-01 | $40.24M 10-Q · filed 2022-11-01 | $39.98M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-07-02 | $28.80M 10-Q · filed 2022-08-09 | $25.18M 10-Q · filed 2022-08-09 | $24.92M derived: sum of 3 quarters · filed 2023-02-07 | $18.94M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-04-02 | -$3.62M 10-Q · filed 2022-05-10 | -$3.88M derived: sum of 2 quarters · filed 2023-02-07 | -$9.86M derived: sum of 3 quarters · filed 2023-02-07 | $4.02M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-01-01 | -$261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | -$6.24M derived: sum of 2 quarters · filed 2023-02-07 | $7.63M derived: sum of 3 quarters · filed 2023-02-07 | $19.06M 10-K · filed 2023-02-07 |
| 2020-10-02 | -$5.98M 10-Q · filed 2021-11-02 | $7.89M derived: sum of 2 quarters · filed 2021-11-02 | $19.32M 10-Q · filed 2021-11-02 | $35.59M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-07-03 | $13.88M 10-Q · filed 2021-08-05 | $25.30M 10-Q · filed 2021-08-05 | $41.57M derived: sum of 3 quarters · filed 2022-02-18 | $66.77M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-04-03 | $11.42M 10-Q · filed 2021-05-06 | $27.69M derived: sum of 2 quarters · filed 2022-02-18 | $52.90M derived: sum of 3 quarters · filed 2022-02-18 | $73.62M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-01-03 | $16.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $41.48M derived: sum of 2 quarters · filed 2022-02-18 | $62.20M derived: sum of 3 quarters · filed 2022-02-18 | $77.10M 10-K · filed 2022-02-18 |
| 2019-09-27 | $25.20M 10-Q · filed 2020-11-05 | $45.93M derived: sum of 2 quarters · filed 2020-11-05 | $60.83M 10-Q · filed 2020-11-05 | -$182.89M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-28 | $20.73M 10-Q · filed 2020-08-06 | $35.62M 10-Q · filed 2020-08-06 | -$208.10M derived: sum of 3 quarters · filed 2020-08-06 | -$205.77M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-29 | $14.90M 10-Q · filed 2020-05-05 | -$228.82M derived: sum of 2 quarters · filed 2020-05-05 | -$226.50M derived: sum of 3 quarters · filed 2020-05-05 | -$225.60M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-28 | -$243.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$241.39M derived: sum of 2 quarters · filed 2020-02-25 | -$240.49M derived: sum of 3 quarters · filed 2020-02-25 | -$237.98M 10-K · filed 2021-02-11 |
| 2018-09-28 | $2.32M 10-Q · filed 2019-10-30 | $3.23M derived: sum of 2 quarters · filed 2019-10-30 | $5.74M 10-Q · filed 2019-10-30 | $6.17M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-29 | $901.00K 10-Q · filed 2019-07-31 | $3.42M 10-Q · filed 2019-07-31 | $3.84M derived: sum of 3 quarters · filed 2020-02-25 | $7.05M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-30 | $2.51M 10-Q · filed 2019-05-01 | $2.94M derived: sum of 2 quarters · filed 2020-02-25 | $6.15M derived: sum of 3 quarters · filed 2020-02-25 | |
| 2017-12-29 | $429.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $3.63M derived: sum of 2 quarters · filed 2020-02-25 | $4.35M 10-K · filed 2020-02-25 | |
| 2017-09-30 | $3.21M 10-Q · filed 2017-11-01 | $3.92M 10-Q · filed 2017-11-01 | ||
| 2017-09-29 | $3.21M 10-Q · filed 2018-11-01 | $3.79M derived: sum of 2 quarters · filed 2018-11-01 | $3.92M 10-Q · filed 2018-11-01 | $3.92M derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-06-30 | $581.00K 10-Q · filed 2018-08-01 | $715.00K 10-Q · filed 2017-08-02 | $715.00K derived: sum of 3 quarters · filed 2018-08-01 | $715.00K derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | $134.00K 10-Q · filed 2017-05-01 | $134.00K derived: sum of 2 quarters · filed 2018-05-02 | $134.00K derived: sum of 3 quarters · filed 2018-05-02 | $134.00K derived: sum of 4 quarters · filed 2018-05-02 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $0.00 derived: sum of 2 quarters · filed 2017-11-01 | $0.00 derived: sum of 3 quarters · filed 2017-11-01 | $0.00 10-K · filed 2017-02-27 |
| 2016-12-30 | $0.00 10-K · filed 2019-02-22 | |||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-01 | $0.00 derived: sum of 2 quarters · filed 2017-11-01 | $0.00 10-Q · filed 2017-11-01 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-02 | $0.00 10-Q · filed 2017-08-02 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-01 | |||
| 2016-01-01 | $55.00K 10-K · filed 2018-02-26 | |||
| 2015-12-31 | $55.00K 10-K · filed 2017-02-27 | |||
| 2014-12-31 | -$182.00K 10-K · filed 2017-02-27 | |||
| 2013-12-31 | -$96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$96.00K derived: sum of 2 quarters · filed 2016-02-29 | -$96.00K derived: sum of 3 quarters · filed 2016-02-29 | -$96.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | $0.00 10-Q · filed 2013-10-30 | $0.00 derived: sum of 2 quarters · filed 2013-10-30 | $0.00 10-Q · filed 2013-10-30 | $74.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-06 | $0.00 10-Q · filed 2013-08-06 | $74.00K derived: sum of 3 quarters · filed 2015-03-02 | $84.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-07 | $74.00K derived: sum of 2 quarters · filed 2015-03-02 | $84.00K derived: sum of 3 quarters · filed 2015-03-02 | $96.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $84.00K derived: sum of 2 quarters · filed 2015-03-02 | $96.00K derived: sum of 3 quarters · filed 2015-03-02 | $107.00K 10-K · filed 2015-03-02 |
| 2012-09-30 | $10.00K 10-Q · filed 2013-10-30 | $22.00K derived: sum of 2 quarters · filed 2013-10-30 | $33.00K 10-Q · filed 2013-10-30 | $1.33M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-06-30 | $12.00K 10-Q · filed 2013-08-06 | $23.00K 10-Q · filed 2013-08-06 | $1.32M derived: sum of 3 quarters · filed 2014-02-20 | $1.32M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-03-31 | $11.00K 10-Q · filed 2013-05-07 | $1.31M derived: sum of 2 quarters · filed 2014-02-20 | $1.31M derived: sum of 3 quarters · filed 2014-02-20 | $1.31M derived: sum of 4 quarters · filed 2014-02-20 |
| 2011-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $1.29M derived: sum of 2 quarters · filed 2014-02-20 | $1.29M derived: sum of 3 quarters · filed 2014-02-20 | $1.29M 10-K · filed 2014-02-20 |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-07 | $0.00 derived: sum of 2 quarters · filed 2012-11-07 | $0.00 10-Q · filed 2012-11-07 | |
| 2011-06-30 | $0.00 10-Q · filed 2012-08-02 | $0.00 10-Q · filed 2012-08-02 | ||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | -$72.00K derived: sum of 2 quarters · filed 2013-02-21 | -$72.00K 10-K · filed 2013-02-21 | |
| 2010-09-30 | -$72.00K 10-Q · filed 2011-10-27 | -$72.00K 10-Q · filed 2011-10-27 | ||
| 2009-12-31 | -$1.29M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |